Newsfeeds - Spark Newswire

1 minute read

Bloomberg Reported Saturday: Danaher Interested In Buying Life Sciences Firm Catalent, Though Deal Is Not Imminent

By Charles Gross

Today, 5:28 AM

https://www.bloomberg.com/news/articles/2023-02-04/danaher-is-said-to-be-interested-in-life-sciences-firm-catalent

CTLT

1 minute read

Barclays Maintains Overweight on Catalent, Lowers Price Target to $58

By Benzinga Newsdesk

Today, 5:28 AM

Barclays analyst Luke Sergott maintains Catalent (NYSE:CTLT) with a Overweight and lowers the price target from $62 to $58.

CTLT

2 minute read

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot

By Vandana Singh

Today, 5:28 AM

Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

BNTX

2 minute read

Acorda Therapeutics Announces New Agreement With Catalent For Long-Term Global Supply Of INBRIJA

By Benzinga Newsdesk

Today, 5:28 AM

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that on December 31, 2022 it entered into a new long-term global supply agreement with Catalent for the manufacture of INBRIJA (levodopa inhalation powder) at its

ACOR

1 minute read

After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023

By Vandana Singh

Today, 5:28 AM

Novo Nordisk A/S (NYSE: NVO) will roll out its obesity treatment, Wegovy (semaglutide), in Europe in 2023 to ensure it has enough supply.

CTLT

1 minute read

Traders Circulate Barclays Note Saying Catalent Had Their 483s Cleared Over The Weekend. The FDA Cleared Both The Belgium And Bloomington Facilities 483s With Voluntary Action Indicated Designations; A Minimally Acceptable State Of Compliance Was Met

By Benzinga Newsdesk

Today, 5:28 AM

Barclays saying that CTLT had their 483s were cleared over the weekend the FDA cleared both the Belgium and Bloomington facilities’ 483s over the weekend with Voluntary Action Indicated (VAI) designations.

CTLT